Citation Impact
Citing Papers
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Overexpression of Id‐1 is associated with poor clinical outcome in node negative breast cancer
2003
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials
2008
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Mitoxantrone
1991
Free Radicals as Mediators of Tissue Injury and Disease
1993 Standout
Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials
2007
Free radical formation by antitumor quinones
1989
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Anthrazykline in der Krebstherapie
1997 Standout
Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: A marker of hormone response
1987
Stage and pattern of metastases in patients with breast cancer
1987
Molecular mechanisms of quinone cytotoxicity
1991 Standout
Proposal for a new model of breast cancer metastatic development
1997
Estrogen and progesterone receptor concordance between primary and recurrent breast cancer
1994
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
1989 Standout
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
PZ-51 (Ebselen) in vivo protection against Adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity
1992
Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestine
1992
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Hormone receptors in malignancy
1992
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
2009
Oxidative mechanisms in the toxicity of metal ions
1995 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer
2004
Microenvironmental regulation of metastasis
2008 Standout
The mitochondrial permeability transition
1995 Standout
Tansley Review No. 111
2000 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Prognostic indicators in patients with pulmonary metastases
1990
Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
2006
Idarubicin
1991
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
2001
NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation
1990
Use of antioxidant supplements during breast cancer treatment: a comprehensive review
2008
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
1989
Antioxidants and Cancer Therapy: A Systematic Review
2004
Inhibition of protein synthesis by glutathione disulfide in the presence of glutathione
1971 StandoutNobel
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
Oxygen-Dependent Microbial Killing by Phagocytes
1978 Standout
Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation
2011
Complete Deficiency of Leukocyte Glucose-6-Phosphate Dehydrogenase with Defective Bactericidal Activity
1972
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Role of Hypoxia-Inducible Factors in Breast Cancer Metastasis
2013 StandoutNobel
X chromosome-linked muscular dystrophy (mdx) in the mouse.
1984 Standout
Combination therapy in combating cancer
2017 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease
1983
Purification and properties of an abrnomal glutathione reductace from human erythrocytes
1969
NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin‐Fe3+
1983
Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction
1973
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
1997 Standout
Familial deficiency of glutathione reductase in human blood cells
1976
Works of Keith Moser being referenced
The clinical course of lung metastases from breast cancer
1988
Glutathionreductase- und Triosephosphatisomerasemangel in Erythrocyten und Thrombocyten bei Pancytopenic (Typ Estren-Damashek)
1968
[Mitoxantrone in the primary treatment of metastasizing breast cancer].
1984
Dietary Induction of Liver Glucose-6-Phosphate Dehydrogenase in the Rat.
1966
The value of prognostic parameters for the stratification of advanced breast cancer patients
1982
[Oestrogen receptors and prognosis in breast cancer].
1980
Simultaneous and Sequential Determinations of Steroid Hormone Receptors in Human Breast Cancer
1985
Pyruvatkinase-Mangel der Erythrocyten bei heredit�rer Myopathie
1971
Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances
1983
Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment
1983